0001209191-22-003192.txt : 20220113
0001209191-22-003192.hdr.sgml : 20220113
20220113163326
ACCESSION NUMBER: 0001209191-22-003192
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220111
FILED AS OF DATE: 20220113
DATE AS OF CHANGE: 20220113
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HEALY JAMES
CENTRAL INDEX KEY: 0001245624
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41201
FILM NUMBER: 22529394
MAIL ADDRESS:
STREET 1: 3000 SAND HILL ROAD, 4-250
CITY: MENLO PARK
STATE: CA
ZIP: 94025
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CinCor Pharma, Inc.
CENTRAL INDEX KEY: 0001868734
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 CLARENDON STREET, 6TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: 8445311834
MAIL ADDRESS:
STREET 1: 200 CLARENDON STREET, 6TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-01-11
0
0001868734
CinCor Pharma, Inc.
CINC
0001245624
HEALY JAMES
C/O CINCOR PHARMA, INC
200 CLARENDON STREET, 6TH FLOOR
BOSTON
MA
02116
1
0
1
0
Common Stock
2022-01-11
4
C
0
5248949
A
5248949
I
By Sofinnova Venture Partners X, L.P.
Common Stock
2022-01-11
4
P
0
325000
16.00
A
5573949
I
By Sofinnova Venture Partners X, L.P.
Series A Preferred Stock
2022-01-11
4
C
0
13571428
0.00
D
Common Stock
3991596
0
I
By Sofinnova Venture Partners X, L.P.
Series B Preferred Stock
2022-01-11
4
C
0
4275000
0.00
D
Common Stock
1257353
0
I
By Sofinnova Venture Partners X, L.P.
Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering (the "IPO") for no additional consideration, on a 3.4:1 basis, and had no expiration date.
The shares are directly held by Sofinnova Venture Partners X, L.P. ("SVP X"). Sofinnova Management X, L.L.C. ("SM X") is the general partner of SVP X. The Reporting Person is a managing member of SM X and may be deemed to share voting and dispositive power over the shares held by SVP X. The Reporting Person disclaims beneficial ownership of the reported securities, except to the extent of his pecuniary interest therein.
/s/ Cathy Rude, Attorney-in-Fact
2022-01-13